Ticker
GRI
Analysis
Gri Bio, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to GRI.
Gri Bio, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to GRI.
GRI
Stock
$3.3M
Health Technology
Biotechnology
USD
Gri Bio, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Designation highlights significant regulatory milestone and provides a potential pathway to seven years of U.S. market exclusivity LA JOLLA, CA, June 18, 2026 (GLOBE NEWSWIRE) -...
Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer, on Wednesday, May 20, 2026 Register for the event here LA JOLLA, CA, May 18, 2026 (GLOBE NEWSWIRE) -- G...
Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international m...
Access the “What This Means” segment here LA JOLLA, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advan...
– Live video webcast on Wednesday, February 11th at 1:00 PM EST LA JOLLA, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biote...
Review valuation context for Gri Bio, Inc..
Review future growth context for Gri Bio, Inc..
Review past performance context for Gri Bio, Inc..
Review financial health context for Gri Bio, Inc..
Review dividend context for Gri Bio, Inc..
Review management context for Gri Bio, Inc..
Review ownership context for Gri Bio, Inc..
Review other information context for Gri Bio, Inc..
Review community context for Gri Bio, Inc..